Funding Rounds
Be Biopharma October 2024 Venture - Series Unknown Funding Round
Be BiopharmaBe Biopharma is developing a proprietary class of engineered B cells as medicines in applications beyond cytotoxicity.
Summary
Stage: Unknown
Raised Amount: $82.00M
Raised Date: 2024-10-22
